Ozempic & Vulvar Health: What Women Need to Know

A new term is circulating on social media – “Ozempic vulva” – describing changes some women are noticing in their genital area after experiencing significant weight loss while using GLP-1 medications like Ozempic, Wegovy, and Mounjaro. While not a formal medical diagnosis, the phrase reflects a real concern for some patients, prompting discussion among both individuals and healthcare professionals.

What is “Ozempic Vulva”?

The term refers to aesthetic and structural changes in the vulvar region following rapid weight loss. These changes can include sagging or deflation of the labia majora (outer lips), laxity of the vulvar skin, a feeling of looseness or reduced support in the vaginal area, and alterations in lubrication. It’s important to understand that the medications themselves aren’t directly altering the vulvar tissue. Instead, the changes are a consequence of losing fat and connective tissue volume throughout the body, including in the genital region. As Dr. Kristi Hustak, a board-certified plastic surgeon, explains, the body loses volume, and the skin and connective tissues don’t necessarily shrink at the same rate.

How Does Weight Loss Impact the Genital Area?

Fat loss isn’t selective; it occurs across the entire body. This includes subcutaneous fat, the fat layer just beneath the skin, and fat within the vulvar area. When this fat is lost quickly, the skin and connective tissues – which provide support and structure – don’t have time to adjust. This can lead to a loss of volume and a more deflated appearance. The phenomenon is similar to what’s been termed “Ozempic face,” where individuals experience hollowing or sagging skin in the face due to rapid weight reduction. The inability to control *where* weight is lost is a key factor in these changes.

Beyond Aesthetics: Potential Physical Effects

While many concerns are aesthetic, the changes can also lead to physical discomfort. Loss of volume and support can cause discomfort during activity or even with everyday clothing. Some women report a feeling of looseness or a change in sensation. It’s crucial to note that vaginal dryness or pelvic floor weakness are typically linked to estrogen deficiency, rather than directly to GLP-1 medications, according to Dr. Natasha Bhuyan, a board-certified family physician.

The Rise of GLP-1 Medications and Increased Awareness

GLP-1 medications, initially developed for managing type 2 diabetes, have gained significant popularity as weight loss aids. These drugs work by controlling appetite and slowing digestion, leading to substantial weight loss for many individuals. A August 2025 RAND report indicated that nearly one in five women aged 50 to 64 are now using a GLP-1 medication, with overall usage higher among women than men. As more people utilize these medications, more individuals are becoming aware of the potential side effects, including those affecting previously unconsidered areas of the body.

What Can Be Done?

If you are experiencing changes in the appearance of your genitalia or physical discomfort due to skin laxity while taking a GLP-1 medication, it’s important to address your concerns with a healthcare professional. Experts recommend starting with a consultation with an ASPS (American Society of Plastic Surgeons) Member Surgeon. You’ll see options available to improve comfort and appearance, though the best approach will depend on the individual’s specific concerns and the severity of the changes.

Addressing Concerns and Seeking Support

It’s vital to remember that concerns about genital health shouldn’t be minimized or cause shame. These changes are a physiological response to significant weight loss and are becoming increasingly recognized. Open communication with a healthcare provider is essential for receiving appropriate guidance and support. Supervised weight loss is also recommended, as a slower, more controlled approach may minimize the extent of these changes. For women considering pregnancy while on GLP-1 medications, careful planning and discussion with a physician are crucial.

The Importance of Further Research

While the term “Ozempic vulva” has gained traction, it’s important to acknowledge that research into the long-term effects of GLP-1 medications on genital health is still evolving. Continued investigation is needed to fully understand the mechanisms behind these changes and to develop effective strategies for prevention and treatment. The current understanding is based on observations and clinical experience, and more robust studies are necessary to provide definitive answers.

awareness of this potential side effect empowers individuals to proactively address their concerns and seek appropriate medical attention. Open dialogue between patients and healthcare providers is key to navigating the complexities of GLP-1 medications and ensuring optimal health outcomes.